LSL Pharma Group Inc (TSE:LSL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LSL Pharma Group Inc., a Canadian pharmaceutical company, has secured a $5 million loan from the Business Development Bank of Canada to pay off short-term debts and support growth initiatives. The loan will help fund the acquisition of Dermolab Pharma and the expansion of Steri-Med Pharma’s manufacturing capacity. This strategic move aims to enhance LSL Pharma’s financial performance and production capabilities.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.